Absorption Rate Improved by Approximately 3.3 Times

Dong-A Pharmaceutical announced on November 27 that it has relaunched its fast-acting liquid pain reliever OneQ series.

Liquid pain reliever 'OneQ' series. Dong-A Pharmaceutical

Liquid pain reliever 'OneQ' series. Dong-A Pharmaceutical

View original image

With this renewal, the three products in the OneQ lineup have been reduced in size compared to the previous soft capsules, making them easier to take. The application of the New Neo-Sol technology has improved the absorption rate in the body by approximately 3.3 times. In addition, the use of natural coloring agents and the assurance of quality stability for 36 months after manufacturing have further enhanced the product’s competitiveness.


The Dong-A Pharmaceutical OneQ lineup consists of three types based on their active ingredients: Eve OneQ, Dex OneQ, and Nap OneQ. Eve OneQ contains 200 mg of ibuprofen as its main ingredient and is effective for headaches, migraines, toothaches, muscle pain, and menstrual pain. Ibuprofen causes less gastrointestinal discomfort and provides not only antipyretic and analgesic effects but also anti-inflammatory action, making it effective for relieving cold symptoms accompanied by inflammation, such as sore throat and muscle pain.


Dex OneQ contains 300 mg of dexibuprofen as its main ingredient and is effective for pain relief, fever reduction, and anti-inflammation. Dexibuprofen, which is made from only the active component of ibuprofen, is particularly effective for rapid pain relief or severe pain. Nap OneQ contains 250 mg of naproxen as its main ingredient and is effective for toothaches, migraines, arthritis, and menstrual pain. Naproxen is known for its strong pain-relieving effects and long half-life, which means its effects last longer compared to other medications.



A representative from Dong-A Pharmaceutical stated, "With this renewal, the OneQ series has improved all key aspects, including ease of administration, absorption, and safety," adding, "The OneQ series will continue to incorporate consumer feedback and establish itself as a pain reliever that provides customized solutions for different types of pain."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing